ARTICLE | Clinical News
Human anti-rabies IgG therapy regulatory update
November 9, 2016 10:01 PM UTC
FDA accepted for review a BLA from Kamada for its human anti-rabies IgG therapy as post-exposure treatment of rabies infection. The PDUFA date is Aug. 29, 2017. Kedrion Group S.p.A. (Barga, Italy) has...